Skip to content

Clinical trials

Withdrawn Hemolysis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemolysis Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20161
20171
20181
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
Alnylam Pharmaceuticals1
Anthea Hospital Bari1
Cedars-Sinai Medical Center1
Kezar Life Sciences, Inc.1
State University of New York - Upstate Medical University1
University Hospitals Cleveland Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemolysis8
Cardiovascular Diseases2
Thrombocytopenia2
Anemia1
Anemia, Hemolytic, Autoimmune1
Anemia, Sickle Cell1
Atypical Hemolytic Uremic Syndrome1
Erythroblastosis, Fetal1
Hematologic Diseases1
Hyperbilirubinemia1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.